In the present study, we designed a pH-responsive drug nanocarrier based on polyamidoamine-modified Fe ₃ O ₄ nanoparticles coated by PEGylated starch- co -poly(acrylic acid).
No takes yet. Share an insight, caveat, or question.
Pourjavadi et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: